ORCID ID: 0000-0001-8470-2496
EDUCATION AND TRAINING
2007: Training at the University of Minnesota, Stem Cell Institute, Minneapolis, USA.
2004: Ph.D. in Biotechnology, Department of Biochemistry and Molecular Biology, University of Ferrara, Italy.
1999: Chemical and Pharmaceutical Technologies Degree, University of Ferrara, Italy (magna cum laude).
EMPLOYMENT
2015-date: Associate Professor of Biochemistry BIO/10, Department of Life Sciences and Biotechnology, University of Ferrara, Italy.
2011-2015: Assistant Professor of Biochemistry BIO/10, Department of Life Sciences and Biotechnology, University of Ferrara, Italy.
2004-2011: Post Doc, Department of Biochemistry and Molecular Biology, University of Ferrara, Italy.
TEACHING COURSES (University of Ferrara)
2015-date: Environmental Biochemistry
2014: Cellular and Biomolecular Therapies
2013: Stem Cells in Regenerative Medicine
2005-2011: Structural Biochemistry
FUNDING
2012: Coordinator, #01/2012 FFC “The read-through approach for the treatment of cystic fibrosis caused by premature termination codons” (Italian Cystic Fibrosis Research Foundation) (2 years).
2011: Principal Investigator, 098/GR-2009-1596647 “Development of non-invasive strategies for prenatal diagnosis of rare diseases based on surface plasmon resonance (SPR)-imaging, peptide nucleic acids probes and PCR-free hybridization” (Young Investigators-Italian Ministry of Health) (4 years).
2011: Principal Investigator, “Chronic Obstructive Pulmonary Disease (COPD) in smokers: identification of pro-inflammatory markers and molecules with anti-inflammatory activity” (Chiesi Foundation) (3 years).
2010: Coordinator, #02/2010 FFC “Novel cellular model system and therapeutic molecules for the development of a read-through approach for CF caused by stop codon mutations of the CFTR gene” (Italian Cystic Fibrosis Research Foundation) (1 year).
2006: Principal Investigator, “Citrus plants as sources of bioactive molecules with pharmaceutical and biomedical applications” (Young researchers-Ferrara University) (1 year).
2000: Principal Investigator, “Peptide Nucleic Acids (PNA) for the identification of genetically modified organisms (GMO) using advanced technologies” (Young researchers-Ferrara University) (1 year).
RESEARCH INTERESTS
-Peptide nucleic acids as tool to modify gene expression and for the diagnosis of genetic diseases using SPR technologies.
-Biological and diagnostic applications of dielectrophoresis (DEP) based Lab-on-a-chip devices to diagnosis and drug research and development.
-Identification of novel compounds as inducers of erythroid differentiation for beta-thalassemia.
-Analysis of anti-inflammatory molecules for cystic fibrosis and COPD diseases.
-Read-through strategy for the treatments of genetic rare diseases caused by nonsense mutations.
PUBLICATIONS (updated December, 2014)
-126 papers in peer-reviewed International Journals (h-index 26, citations/year 122,88)
-6 book chapters
PATENTS
Bianchi N, Borgatti M, Gambari R, Lampronti I (2009). Use of angelicin and of its structural analogues for the treatment of thalassemia. United States Patent 7,572,827, Università degli Studi di Ferrara; Associazione Veneta per la Lotta alla Talassemia.
AWARDS AND HONORS
2003: Interuniversity Consortium for Biotechnology (CIB) Young Researcher prize
PROFESSIONAL SERVICES
-Member of the Medical Sciences and Biotechnology PhD, University of Ferrara, Italy.
-Invited reviewer for Biomaterials, eCAM, Journal of Ethnopharmacology, Nutrition Research, Pharmaceutical Biology.
-Member of the Editorial Board of Evidence-Based Complementary and Alternative Medicine.
-Member of Directive Council of Laboratory on Pharmacological and Pharmacogenomic Therapy of Thalassemia, University of Ferrara, Italy.
EDUCATION AND TRAINING
2007: Training at the University of Minnesota, Stem Cell Institute, Minneapolis, USA.
2004: Ph.D. in Biotechnology, Department of Biochemistry and Molecular Biology, University of Ferrara, Italy.
1999: Chemical and Pharmaceutical Technologies Degree, University of Ferrara, Italy (magna cum laude).
EMPLOYMENT
2015-date: Associate Professor of Biochemistry BIO/10, Department of Life Sciences and Biotechnology, University of Ferrara, Italy.
2011-2015: Assistant Professor of Biochemistry BIO/10, Department of Life Sciences and Biotechnology, University of Ferrara, Italy.
2004-2011: Post Doc, Department of Biochemistry and Molecular Biology, University of Ferrara, Italy.
TEACHING COURSES (University of Ferrara)
2015-date: Environmental Biochemistry
2014: Cellular and Biomolecular Therapies
2013: Stem Cells in Regenerative Medicine
2005-2011: Structural Biochemistry
FUNDING
2012: Coordinator, #01/2012 FFC “The read-through approach for the treatment of cystic fibrosis caused by premature termination codons” (Italian Cystic Fibrosis Research Foundation) (2 years).
2011: Principal Investigator, 098/GR-2009-1596647 “Development of non-invasive strategies for prenatal diagnosis of rare diseases based on surface plasmon resonance (SPR)-imaging, peptide nucleic acids probes and PCR-free hybridization” (Young Investigators-Italian Ministry of Health) (4 years).
2011: Principal Investigator, “Chronic Obstructive Pulmonary Disease (COPD) in smokers: identification of pro-inflammatory markers and molecules with anti-inflammatory activity” (Chiesi Foundation) (3 years).
2010: Coordinator, #02/2010 FFC “Novel cellular model system and therapeutic molecules for the development of a read-through approach for CF caused by stop codon mutations of the CFTR gene” (Italian Cystic Fibrosis Research Foundation) (1 year).
2006: Principal Investigator, “Citrus plants as sources of bioactive molecules with pharmaceutical and biomedical applications” (Young researchers-Ferrara University) (1 year).
2000: Principal Investigator, “Peptide Nucleic Acids (PNA) for the identification of genetically modified organisms (GMO) using advanced technologies” (Young researchers-Ferrara University) (1 year).
RESEARCH INTERESTS
-Peptide nucleic acids as tool to modify gene expression and for the diagnosis of genetic diseases using SPR technologies.
-Biological and diagnostic applications of dielectrophoresis (DEP) based Lab-on-a-chip devices to diagnosis and drug research and development.
-Identification of novel compounds as inducers of erythroid differentiation for beta-thalassemia.
-Analysis of anti-inflammatory molecules for cystic fibrosis and COPD diseases.
-Read-through strategy for the treatments of genetic rare diseases caused by nonsense mutations.
PUBLICATIONS (updated December, 2014)
-126 papers in peer-reviewed International Journals (h-index 26, citations/year 122,88)
-6 book chapters
PATENTS
Bianchi N, Borgatti M, Gambari R, Lampronti I (2009). Use of angelicin and of its structural analogues for the treatment of thalassemia. United States Patent 7,572,827, Università degli Studi di Ferrara; Associazione Veneta per la Lotta alla Talassemia.
AWARDS AND HONORS
2003: Interuniversity Consortium for Biotechnology (CIB) Young Researcher prize
PROFESSIONAL SERVICES
-Member of the Medical Sciences and Biotechnology PhD, University of Ferrara, Italy.
-Invited reviewer for Biomaterials, eCAM, Journal of Ethnopharmacology, Nutrition Research, Pharmaceutical Biology.
-Member of the Editorial Board of Evidence-Based Complementary and Alternative Medicine.
-Member of Directive Council of Laboratory on Pharmacological and Pharmacogenomic Therapy of Thalassemia, University of Ferrara, Italy.
